Aneurysm occlusion device containing bioactive and biocompatible copolymer shell and biocompatible metallic frame member

1. An endovascular medical device comprising:

a polymeric member defining an interior chamber, wherein the polymeric member is constructed from a copolymer comprising a biocompatible polyurethane and a bioactive polysaccharide, wherein the bioactive polysaccharide is incorporated into the biocompatible polyurethane backbone of the copolymer; and

a biocompatible metallic frame member comprising one or more components constructed from a NiTi alloy having a transformation temperature below a patient's body temperature, disposed within the interior chamber, and adapted to structurally support the polymeric member.

2. The medical device of claim 1 , wherein the bioactive polysaccharide is a bioactive glycosaminoglycan.

3. The medical device of claim 2 , wherein the bioactive glycosaminoglycan is a member selected from the group consisting of a suitable salt of hyaluronic acid and a suitable salt of heparin.

4. The medical device of claim 3 , wherein the salt of hyaluronic acid is a member selected from the group consisting of a cetylpyridinium salt and a tetrabutylammonium salt, and wherein the salt of heparin is a dimethyldioctadecylammonium salt.

5. The medical device of claims 4 , wherein the salt of hyaluronic acid has 5 to 10,000 repeating units, and wherein the dimethyldioctadecylammonium salt of heparin has 5 to 65 repeating units.

6. The medical device of claim 1 , wherein the weight content of the bioactive polysaccharide is in the range of about 0.05% to about 30%.

7. The medical device of claim 6 , wherein the high and low range endpoints of the weight content of the bioactive polysaccharide are any combination of members selected from the group consisting of 0.05%, 0.1%, 0.33%, 0.66%, 1.3%, 2.0%, 5.4%, 10% and 30%.

8. The medical device of claim 7 , comprising the cetylpyridinium salt of hyaluronic acid.

9. The medical device of claim 1 , wherein the biocompatible urethane is the reaction product of 4,4′-methylene-di-(p-phenyl isocyanate) and poly(tetramethylene oxide) n , and further reacted with 1,4-butanediol, and wherein n=10 to 40.

10. The medical device of claim 1 , wherein the biocompatible urethane is the reaction product of 4,4′-methylene-di-(p-phenyl isocyanate) and poly(tetramethylene oxide) n , and further reacted with 1,4-butanediol, and wherein n=10 to 40.

11. The medical device of claim 1 , wherein the biocompatible urethane is the reaction product of a suitable isocyanate-containing molecule and a suitable poly(C 2-10 alkylene oxide) n , and further reacted with a suitable C 4-50 diol-containing molecule, wherein n=10 to 40, wherein the C 2-10 alkylene is linear or branched, substituted or un-substituted, and wherein the C 4-50 is linear or branched, substituted or un-substituted.

12. The medical device of claim 1 , wherein the polymeric member has a wall thickness in the range of 0.05 to 0.4 mm.

13. The medical device of claim 12 , wherein the polymeric member is adapted to substantially conform to a vascular aneurysm.

14. The medical device of claim 1 , wherein the NiTi alloy comprises in the range of about 49 to about 51 wt. % Ni and in the range of about 51 to about 49 wt. % Ti.

15. The medical device of claim 14 , wherein the metallic frame member comprises a single component.

16. The medical device of claim 14 , wherein the metallic frame member is in the shape of a coil.

17. An endovascular medical device comprising:

a polymeric member defining an interior chamber and constructed from an elastic, hemocompatible polymer, wherein the elastic, hemocompatible polymer is modified with an anti-thrombotic agent and wherein the elastic, hemocompatible polymer is a member selected from the group consisting of poly(ethylene glycol), poly(vinyl alcohol), polytetrafluoroethylene, polyethylene terephthalate, poly(hydroxyethyl methacrylate), poly(hydroxyethyl acrylate), and a copolymer thereof, and,

a biocompatible metallic frame member comprising one or more components constructed from a NiTi alloy having a transformation temperature below a patient's body temperature, disposed within the interior chamber, and adapted to structurally support the polymeric member.

18. The medical device of claim 17 , wherein the copolymer is a member selected from the group consisting of poly(ethylene glycol) diacrylate, poly(ethylene glycol) dimethacrylate and acrylated poly(vinyl alcohol).

19. The medical device of claim 17 , wherein the anti-thrombotic modified derivative includes the hemocompatible polymer modified by an anti-thrombotic agent selected from the group consisting of heparin, chitosan and a nitric oxide donor molecule.

20. The medical device of claim 17 , wherein the anti-thrombotic modified derivative is a member selected from the group consisting of heparin-releasing polyvinylpyrrolidone, heparin-releasing methacrylate, heparin-releasing polyester, nitric oxide-releasing polyester, and nitric oxide-releasing polyvinyl chloride.

21. The medical device of claim 17 , wherein the polymeric member has a wall thickness in the range of 0.05 to 0.4 mm.

22. The medical device of claim 17 , wherein the polymeric member is adapted to substantially conform to a vascular aneurysm.

23. The medical device of claim 17 , wherein the alloy comprises in the range of about 49 to about 51 wt. % Ni and in the range of about 51 to about 49 wt. % Ti.

24. The medical device of claim 23 , wherein the metallic frame member comprises a single component.

25. The medical device of claim 24 , wherein the metallic frame member is in the shape of a coil.